Ambev S.A. (NYSE:ABEV) saw a downside of -1.15% to close Monday at $2.57 after subtracting -$0.03 on the day. The 5-day average trading volume is 28,030,639 shares of the company’s common stock. It has gained $2.76 in the past week and touched a new high 2 times within the past 5 days. An average of 22,967,510 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 26,474,639.
ABEV’s 1-month performance is -6.88% or -$0.24 on its low of $2.55 reached on 01/23/23. The company’s shares have touched a 52-week low of $2.42 and high of $3.32, with the stock’s rally to the 52-week high happening on 01/10/23. YTD, ABEV has lost -5.51% or -$0.15 and has reached a new high 4 times. However, the current price is down -22.47% from the 52-week high price.
ABEV stock has a beta of 1.05. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 2.69 while the price-to-book (PB) in the most recent quarter is 2.32, with the price to cash flow ratio at 65.36.
Ambev S.A.’s quick ratio for the period ended September 29 was 0.80, with the current ratio over the same period at 1.20. As well, the company’s long term debt to equity for the quarter ending September 29 was 0.02, while the total debt to equity was 0.03. In terms of profitability, the gross margin trailing 12 months is 49.50%. The firm’s gross profit as reported stood at $6.89 billion against revenue of $13.5 billion.
For the quarterly period ending September 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income shrunk -372.67% to $2.41 billion, while revenue of $0.0 was 100.0% off the previous quarter. Analysts expected ABEV to announce $0.03 per share in earnings in its latest quarter, but it posted $0.04, representing a 33.30% surprise. EBITDA for the quarter stood at more than $1.03 billion. ABEV stock balance sheet for the quarter ending September 29 shows that total liabilities totaled 9.64 billion, with total debt at $3.42 billion.
Let’s look briefly at Ambev S.A. (ABEV) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 23 January was 29.70% to suggest the stock is trending oversold, with historical volatility in this time period at 19.37%.
The stock’s 5-day moving average is $2.63, reflecting a -5.17% or -$0.14 change from its current price. ABEV is currently trading -6.55% above its 20-day SMA, -15.46% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -19.69% and SMA200 by-19.69%.
Stochastic %K and %D was 12.13% and 23.00% and the average true range (ATR) pointed at 0.08. The RSI (14) points at 34.63%, while the 14-day stochastic is at 8.70% with the period’s ATR at 0.08. The stock’s 9-day MACD Oscillator is pointing at -0.08 and -0.08 on the 14-day charts.
In the most recent analyst report for Ambev S.A. (NYSE: ABEV), UBS upgraded it to a Buy rating. They previously had a Sell rating on the stock. Analysts offering their rating for ABEV stock have a consensus rating for the stock as Overweight. Currently, 2 brokerage advisors rate ABEV as a “sell,”, while 4 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 1 rates the stock as overweight while 10 have offered a “buy” rating.
What is ABEV’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $2.40 and a high of $5.00, with their median price target at $3.40. Looking at these predictions, the average price target given by analysts is for Ambev S.A. (ABEV) stock is $3.56.